Evidence map›Paper›PMID 31297292›Full record

ArticleJournal of pharmaceutical analysis2019

Qualitative and quantitative assessment of related substances in the Compound Ketoconazole and Clobetasol Propionate Cream by HPLC-TOF-MS and HPLC.

Wenling Yang, Xiaomei Yang, Fanghua Shi, Zhigang Liao, Yongkun Liang, Liangzhong Yu, Ruixun Wang, Qing Li, Kaishun Bi

Abstract read
In one paragraph

Article in Journal of pharmaceutical analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Sulfur cream blowing and parching combined with compound ketoconazole creamAmerican journal of translational research · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wenling YangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xiaomei YangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Fanghua ShiSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Zhigang LiaoG.D China Resources Shunfeng Pharmaceutical Co. Ltd, Guangdong 528300, China.
Yongkun LiangG.D China Resources Shunfeng Pharmaceutical Co. Ltd, Guangdong 528300, China.
Liangzhong YuG.D China Resources Shunfeng Pharmaceutical Co. Ltd, Guangdong 528300, China.
Ruixun WangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Qing LiSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Kaishun BiSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Related substances in pharmaceutical formulations are associated with their safety, efficacy and stability. However, there is no overall study already published on the assessment of related substances in the Compound Ketoconazole and Clobetasol Propionate Cream. In this work, a reliable HPLC-TOF-MS qualitative method was developed for the analysis of related substances in this preparation with a quick and easy extraction procedure. Besides the active pharmaceutical ingredients, two compounds named ketoconazole impurity B' optical isomer and ketoconazole impurity E were identified. Furthermore, a new HPLC method for qualitative and quantitative assessment on related substances and degradation products, which were found in the stability test, was established and validated. The single standard to determine multi-components method was applied in the quantitative analysis, which was an effective way for reducing cost and improving accuracy. This study can provide a creative idea for routine analysis of quality control of the Compound Ketoconazole and Clobetasol Propionate Cream.

Indexed as

Compound Ketoconazole and Clobetasol Propionate CreamHPLCHPLC-TOF-MSKetoconazole impurity B' optical isomerKetoconazole impurity EQuality control

Identifiers

PMID31297292
PMCPMC6598455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.